|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:SOD2-CHMP1A (FusionGDB2 ID:84531) |
Fusion Gene Summary for SOD2-CHMP1A |
Fusion gene summary |
Fusion gene information | Fusion gene name: SOD2-CHMP1A | Fusion gene ID: 84531 | Hgene | Tgene | Gene symbol | SOD2 | CHMP1A | Gene ID | 100129518 | 5119 |
Gene name | SOD2 overlapping transcript 1 | charged multivesicular body protein 1A | |
Synonyms | SOD2 | CHMP1|PCH8|PCOLN3|PRSM1|VPS46-1|VPS46A | |
Cytomap | 6q25.3 | 16q24.3 | |
Type of gene | ncRNA | protein-coding | |
Description | Superoxide dismutase [Mn], mitochondrial | charged multivesicular body protein 1acharged multivesicular body protein 1/chromatin modifying protein 1chromatin modifying protein 1Aprocollagen (type III) N-endopeptidaseprotease, metallo, 1, 33kDvacuolar protein sorting-associated protein 46-1 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | Q9HD42 | |
Ensembl transtripts involved in fusion gene | ENST00000546087, ENST00000538183, ENST00000367055, ENST00000367054, ENST00000444946, ENST00000337404, ENST00000452684, ENST00000535372, | ENST00000397901, ENST00000253475, ENST00000535997, ENST00000550102, ENST00000547614, | |
Fusion gene scores | * DoF score | 11 X 13 X 4=572 | 45 X 11 X 21=10395 |
# samples | 16 | 48 | |
** MAII score | log2(16/572*10)=-1.83794324189103 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(48/10395*10)=-4.43671154213721 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: SOD2 [Title/Abstract] AND CHMP1A [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | SOD2(160113693)-CHMP1A(89713739), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | SOD2-CHMP1A seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | CHMP1A | GO:0007076 | mitotic chromosome condensation | 11559747 |
Tgene | CHMP1A | GO:0016192 | vesicle-mediated transport | 11559748 |
Tgene | CHMP1A | GO:0016458 | gene silencing | 11559747 |
Tgene | CHMP1A | GO:0045892 | negative regulation of transcription, DNA-templated | 11559747 |
Fusion gene breakpoints across SOD2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across CHMP1A (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | CESC | TCGA-VS-A953-01A | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Top |
Fusion Gene ORF analysis for SOD2-CHMP1A |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000546087 | ENST00000397901 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000546087 | ENST00000253475 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000546087 | ENST00000535997 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000546087 | ENST00000550102 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
5CDS-5UTR | ENST00000546087 | ENST00000547614 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000538183 | ENST00000397901 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
In-frame | ENST00000538183 | ENST00000253475 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000538183 | ENST00000535997 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000538183 | ENST00000550102 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
5CDS-5UTR | ENST00000538183 | ENST00000547614 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
In-frame | ENST00000367055 | ENST00000397901 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000367055 | ENST00000253475 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
In-frame | ENST00000367055 | ENST00000535997 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
In-frame | ENST00000367055 | ENST00000550102 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
5CDS-5UTR | ENST00000367055 | ENST00000547614 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
In-frame | ENST00000367054 | ENST00000397901 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000367054 | ENST00000253475 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
In-frame | ENST00000367054 | ENST00000535997 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
In-frame | ENST00000367054 | ENST00000550102 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
5CDS-5UTR | ENST00000367054 | ENST00000547614 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000444946 | ENST00000397901 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
In-frame | ENST00000444946 | ENST00000253475 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000444946 | ENST00000535997 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000444946 | ENST00000550102 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
5CDS-5UTR | ENST00000444946 | ENST00000547614 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000337404 | ENST00000397901 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
In-frame | ENST00000337404 | ENST00000253475 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000337404 | ENST00000535997 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
Frame-shift | ENST00000337404 | ENST00000550102 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
5CDS-5UTR | ENST00000337404 | ENST00000547614 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
intron-3CDS | ENST00000452684 | ENST00000397901 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
intron-3CDS | ENST00000452684 | ENST00000253475 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
intron-3CDS | ENST00000452684 | ENST00000535997 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
intron-3CDS | ENST00000452684 | ENST00000550102 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
intron-5UTR | ENST00000452684 | ENST00000547614 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
intron-3CDS | ENST00000535372 | ENST00000397901 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
intron-3CDS | ENST00000535372 | ENST00000253475 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
intron-3CDS | ENST00000535372 | ENST00000535997 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
intron-3CDS | ENST00000535372 | ENST00000550102 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
intron-5UTR | ENST00000535372 | ENST00000547614 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000538183 | SOD2 | chr6 | 160113693 | - | ENST00000253475 | CHMP1A | chr16 | 89713739 | - | 2354 | 387 | 95 | 877 | 260 |
ENST00000367055 | SOD2 | chr6 | 160113693 | - | ENST00000397901 | CHMP1A | chr16 | 89713739 | - | 2267 | 293 | 1 | 783 | 260 |
ENST00000367055 | SOD2 | chr6 | 160113693 | - | ENST00000535997 | CHMP1A | chr16 | 89713739 | - | 2235 | 293 | 1 | 783 | 260 |
ENST00000367055 | SOD2 | chr6 | 160113693 | - | ENST00000550102 | CHMP1A | chr16 | 89713739 | - | 809 | 293 | 1 | 783 | 260 |
ENST00000367054 | SOD2 | chr6 | 160113693 | - | ENST00000397901 | CHMP1A | chr16 | 89713739 | - | 2261 | 287 | 61 | 777 | 238 |
ENST00000367054 | SOD2 | chr6 | 160113693 | - | ENST00000535997 | CHMP1A | chr16 | 89713739 | - | 2229 | 287 | 61 | 777 | 238 |
ENST00000367054 | SOD2 | chr6 | 160113693 | - | ENST00000550102 | CHMP1A | chr16 | 89713739 | - | 803 | 287 | 61 | 777 | 238 |
ENST00000444946 | SOD2 | chr6 | 160113693 | - | ENST00000253475 | CHMP1A | chr16 | 89713739 | - | 2267 | 300 | 8 | 790 | 260 |
ENST00000337404 | SOD2 | chr6 | 160113693 | - | ENST00000253475 | CHMP1A | chr16 | 89713739 | - | 2304 | 337 | 45 | 827 | 260 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000538183 | ENST00000253475 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - | 0.20473322 | 0.7952668 |
ENST00000367055 | ENST00000397901 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - | 0.19669642 | 0.80330354 |
ENST00000367055 | ENST00000535997 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - | 0.18685873 | 0.8131413 |
ENST00000367055 | ENST00000550102 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - | 0.0089651 | 0.9910349 |
ENST00000367054 | ENST00000397901 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - | 0.18558654 | 0.8144135 |
ENST00000367054 | ENST00000535997 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - | 0.17482673 | 0.8251733 |
ENST00000367054 | ENST00000550102 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - | 0.008161354 | 0.99183863 |
ENST00000444946 | ENST00000253475 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - | 0.21009488 | 0.7899051 |
ENST00000337404 | ENST00000253475 | SOD2 | chr6 | 160113693 | - | CHMP1A | chr16 | 89713739 | - | 0.2231694 | 0.77683055 |
Top |
Fusion Genomic Features for SOD2-CHMP1A |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for SOD2-CHMP1A |
Go to FGviewer for the breakpoints of chr6:160113693-chr16:89713739 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | CHMP1A |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Probable peripherally associated component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. Involved in cytokinesis. Involved in recruiting VPS4A and/or VPS4B to the midbody of dividing cells. May also be involved in chromosome condensation. Targets the Polycomb group (PcG) protein BMI1/PCGF4 to regions of condensed chromatin. May play a role in stable cell cycle progression and in PcG gene silencing. {ECO:0000269|PubMed:11559747, ECO:0000269|PubMed:11559748, ECO:0000269|PubMed:19129479, ECO:0000269|PubMed:23045692}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | CHMP1A | chr6:160113693 | chr16:89713739 | ENST00000397901 | 3 | 7 | 102_124 | 84.0 | 197.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | CHMP1A | chr6:160113693 | chr16:89713739 | ENST00000397901 | 3 | 7 | 185_195 | 84.0 | 197.0 | Motif | Note=MIT-interacting motif |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | CHMP1A | chr6:160113693 | chr16:89713739 | ENST00000397901 | 3 | 7 | 5_47 | 84.0 | 197.0 | Coiled coil | Ontology_term=ECO:0000255 |
Top |
Fusion Gene Sequence for SOD2-CHMP1A |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000538183_ENST00000253475_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(transcript)=2354nt_BP=387nt CGGGGCGGCGGTGCCCTTGCGGCGCAGCTGGGGTCGCGGCCCTGCTCCCCGCGCTTTCTTAAGGCCCGCGGGCGGCGCAGGAGCGGCACT CGTGGCTGTGGTGGCTTCGGCAGCGGCTTCAGCAGATCGGCGGCATCAGCGGTAGCACCAGCACTAGCAGCATGTTGAGCCGGGCAGTGT GCGGCACCAGCAGGCAGCTGGCTCCGGTTTTGGGGTATCTGGGCTCCAGGCAGAAGCACAGCCTCCCCGACCTGCCCTACGACTACGGCG CCCTGGAACCTCACATCAACGCGCAGATCATGCAGCTGCACCACAGCAAGCACCACGCGGCCTACGTGAACAACCTGAACGTCACCGAGG AGAAGTACCAGGAGGCGTTGGCCAAGGGTGACCAAGAATATGGCCCAGGTGACCAAAGCCCTGGACAAGGCCCTGAGCACCATGGACCTG CAGAAGGTCTCCTCAGTGATGGACAGGTTCGAGCAGCAGGTGCAGAACCTGGACGTCCATACATCGGTGATGGAGGACTCCATGAGCTCG GCCACCACCCTGACCACGCCGCAGGAGCAGGTGGACAGCCTCATCATGCAGATCGCCGAGGAGAATGGCCTGGAGGTGCTGGACCAGCTC AGCCAGCTGCCCGAGGGCGCCTCTGCCGTGGGCGAGAGCTCTGTGCGCAGCCAGGAGGACCAGCTGTCACGGAGGTTGGCCGCCTTGAGG AACTAGCCGTGCCCCGCCGGTGTGCACCGCCTCTGCCCCGTGATGTGCTGGAAGGCTCCTGTCCTCTCCCCACCGCGTCTTGCCTTTGTG CTGACCCCGCGGGGCTGCGGCCGGCAGCCACTCTGCGTCTCTCACCTGCCAGGCCTGCGTGGCCTTAGGGTTGTTCCTGTTCTTTTAGGT TGGGCGGTGGGTCTGTGTCCTGGTGTTGAGTTTCTGCAAATTTCTGGGGGTGATTTCTGTGACTCTGGGCCCACAGCGGGGAGGCCAAGA GGGGCCCTGTGGACTTTCACCCAGCACTGTGGGGGCCTTCAGACTCTGGGGCAGCAGACATGCTGCTTCCCATCAGCCAGAGGGGGTCAG GGCTGCCCTGTTGCCAAACAACTCCCTGAGGCCTCTCCGCACCACCTCAGCGGGCAGGAGGTCCCACCATGTGGACAGACATAGCCCAAG GAGGCACCACAGGTCTATGTGTGCTGGGGGATGTCAGGTGCCACCCAACGCTGTCCTGGTGGTATTTACAATGACATCCTCCTCCTCCAT CACTCCAGGGGTGGTGTCTCGGCCGCCCCTACCAGCTGGCTGAGCCCCCTGGCCTCCTGCGCTCCCTCACTTCCCTCAGTTCCCAAAGCT GCCCAGTCCATGGGGACAGAACCGTCACTCAGATCCACATTCAAGTGTGCCCACCCTGCAGTCTTCATCCTCACTCAGCTGCTGCCTCTG GAGGTGCCTTTGGCCACATGTGCTGTGCTGTTTGTCTCCTCGACAGGGAGCCTGTCCACCAGCAGGCTGCGGTCCCAGCGGGTGCGTCTG CAGCTCCTCCCCTTGGGCAGCCTGGTTCTCCCGGAGGACCTTTCCTTGGGGCCCTGCTTCATGACGATGCTGCCTGTGTCACCCTCTACC ATCTGTAAACAACTGGGTGCCTTCCCCGACCACACCCCAATGCCTTCCCAGCTTGGAAGCCAAGGCAGCTGATGAAGGGAGCTCAGGAGA GCCGTCTTCAGCTGGGCTGGGGTTGGGGCTGCTGTGAGGAAAACCTGCCATTGTGGCCCTGGAGAGTCACCAGCAGCTCTTGGGAAGGAC TTGCTGGGAGGCTGAGAGAGGCTTTGGGCACAGCCTGCTGTCTTTTCCATTTCCTAAAGTTTACTTCATTGTCTTGAGGCTTCCAGGTTT TGTTTTTGTTTTTGCCAAAGTAGAAAAGGCAGGTGGTGGGCGGCTGGCAGGGAGTGCGGGTCCCCGCCCCTCTTCAGTCCTGCCCTCCCC TCCTCAGTCCTGCCCACCCCGTGCAGCCCATGCTGAGGCTGCAGTGGTGTCGTGGGTGTTACGTGCAGGAACGTGGAGACCCTGACGTGG GCTCACTGCGTTTGGTTTTCTTTTCAGAACTTGGGAGCCCCCAGGGAGGGGCTAGTGTTGGTAGGTCCTAGACGTGGTTCCCTCCAGCCT CCCCAAAATCAACCCTGGTGTTGAGAGAACGTCCTTCTGTCCATCGTGGGTAACAGCCTTGGGGAGGGTGCAGAGCTCTGCAGAGCCATG GGCCAGGTGGGGCTGCCTCAGTCCTGTCCCCTTGGGCACTGAGGAGAGGGGCCCATTCACCTTTCTCCTAGAATGCTGTTGTAAATAAAC >In-frame_ENST00000538183_ENST00000253475_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(amino acids)=260AA_start in transcript=95_stop in transcript=877 MWWLRQRLQQIGGISGSTSTSSMLSRAVCGTSRQLAPVLGYLGSRQKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEK YQEALAKGDQEYGPGDQSPGQGPEHHGPAEGLLSDGQVRAAGAEPGRPYIGDGGLHELGHHPDHAAGAGGQPHHADRRGEWPGGAGPAQP -------------------------------------------------------------- >In-frame_ENST00000367055_ENST00000397901_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(transcript)=2267nt_BP=293nt GCTGTGGTGGCTTCGGCAGCGGCTTCAGCAGATCGGCGGCATCAGCGGTAGCACCAGCACTAGCAGCATGTTGAGCCGGGCAGTGTGCGG CACCAGCAGGCAGCTGGCTCCGGTTTTGGGGTATCTGGGCTCCAGGCAGAAGCACAGCCTCCCCGACCTGCCCTACGACTACGGCGCCCT GGAACCTCACATCAACGCGCAGATCATGCAGCTGCACCACAGCAAGCACCACGCGGCCTACGTGAACAACCTGAACGTCACCGAGGAGAA GTACCAGGAGGCGTTGGCCAAGGGTGACCAAGAATATGGCCCAGGTGACCAAAGCCCTGGACAAGGCCCTGAGCACCATGGACCTGCAGA AGGTCTCCTCAGTGATGGACAGGTTCGAGCAGCAGGTGCAGAACCTGGACGTCCATACATCGGTGATGGAGGACTCCATGAGCTCGGCCA CCACCCTGACCACGCCGCAGGAGCAGGTGGACAGCCTCATCATGCAGATCGCCGAGGAGAATGGCCTGGAGGTGCTGGACCAGCTCAGCC AGCTGCCCGAGGGCGCCTCTGCCGTGGGCGAGAGCTCTGTGCGCAGCCAGGAGGACCAGCTGTCACGGAGGTTGGCCGCCTTGAGGAACT AGCCGTGCCCCGCCGGTGTGCACCGCCTCTGCCCCGTGATGTGCTGGAAGGCTCCTGTCCTCTCCCCACCGCGTCTTGCCTTTGTGCTGA CCCCGCGGGGCTGCGGCCGGCAGCCACTCTGCGTCTCTCACCTGCCAGGCCTGCGTGGCCTTAGGGTTGTTCCTGTTCTTTTAGGTTGGG CGGTGGGTCTGTGTCCTGGTGTTGAGTTTCTGCAAATTTCTGGGGGTGATTTCTGTGACTCTGGGCCCACAGCGGGGAGGCCAAGAGGGG CCCTGTGGACTTTCACCCAGCACTGTGGGGGCCTTCAGACTCTGGGGCAGCAGACATGCTGCTTCCCATCAGCCAGAGGGGGTCAGGGCT GCCCTGTTGCCAAACAACTCCCTGAGGCCTCTCCGCACCACCTCAGCGGGCAGGAGGTCCCACCATGTGGACAGACATAGCCCAAGGAGG CACCACAGGTCTATGTGTGCTGGGGGATGTCAGGTGCCACCCAACGCTGTCCTGGTGGTATTTACAATGACATCCTCCTCCTCCATCACT CCAGGGGTGGTGTCTCGGCCGCCCCTACCAGCTGGCTGAGCCCCCTGGCCTCCTGCGCTCCCTCACTTCCCTCAGTTCCCAAAGCTGCCC AGTCCATGGGGACAGAACCGTCACTCAGATCCACATTCAAGTGTGCCCACCCTGCAGTCTTCATCCTCACTCAGCTGCTGCCTCTGGAGG TGCCTTTGGCCACATGTGCTGTGCTGTTTGTCTCCTCGACAGGGAGCCTGTCCACCAGCAGGCTGCGGTCCCAGCGGGTGCGTCTGCAGC TCCTCCCCTTGGGCAGCCTGGTTCTCCCGGAGGACCTTTCCTTGGGGCCCTGCTTCATGACGATGCTGCCTGTGTCACCCTCTACCATCT GTAAACAACTGGGTGCCTTCCCCGACCACACCCCAATGCCTTCCCAGCTTGGAAGCCAAGGCAGCTGATGAAGGGAGCTCAGGAGAGCCG TCTTCAGCTGGGCTGGGGTTGGGGCTGCTGTGAGGAAAACCTGCCATTGTGGCCCTGGAGAGTCACCAGCAGCTCTTGGGAAGGACTTGC TGGGAGGCTGAGAGAGGCTTTGGGCACAGCCTGCTGTCTTTTCCATTTCCTAAAGTTTACTTCATTGTCTTGAGGCTTCCAGGTTTTGTT TTTGTTTTTGCCAAAGTAGAAAAGGCAGGTGGTGGGCGGCTGGCAGGGAGTGCGGGTCCCCGCCCCTCTTCAGTCCTGCCCTCCCCTCCT CAGTCCTGCCCACCCCGTGCAGCCCATGCTGAGGCTGCAGTGGTGTCGTGGGTGTTACGTGCAGGAACGTGGAGACCCTGACGTGGGCTC ACTGCGTTTGGTTTTCTTTTCAGAACTTGGGAGCCCCCAGGGAGGGGCTAGTGTTGGTAGGTCCTAGACGTGGTTCCCTCCAGCCTCCCC AAAATCAACCCTGGTGTTGAGAGAACGTCCTTCTGTCCATCGTGGGTAACAGCCTTGGGGAGGGTGCAGAGCTCTGCAGAGCCATGGGCC AGGTGGGGCTGCCTCAGTCCTGTCCCCTTGGGCACTGAGGAGAGGGGCCCATTCACCTTTCTCCTAGAATGCTGTTGTAAATAAACAAAT >In-frame_ENST00000367055_ENST00000397901_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(amino acids)=260AA_start in transcript=1_stop in transcript=783 LWWLRQRLQQIGGISGSTSTSSMLSRAVCGTSRQLAPVLGYLGSRQKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEK YQEALAKGDQEYGPGDQSPGQGPEHHGPAEGLLSDGQVRAAGAEPGRPYIGDGGLHELGHHPDHAAGAGGQPHHADRRGEWPGGAGPAQP -------------------------------------------------------------- >In-frame_ENST00000367055_ENST00000535997_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(transcript)=2235nt_BP=293nt GCTGTGGTGGCTTCGGCAGCGGCTTCAGCAGATCGGCGGCATCAGCGGTAGCACCAGCACTAGCAGCATGTTGAGCCGGGCAGTGTGCGG CACCAGCAGGCAGCTGGCTCCGGTTTTGGGGTATCTGGGCTCCAGGCAGAAGCACAGCCTCCCCGACCTGCCCTACGACTACGGCGCCCT GGAACCTCACATCAACGCGCAGATCATGCAGCTGCACCACAGCAAGCACCACGCGGCCTACGTGAACAACCTGAACGTCACCGAGGAGAA GTACCAGGAGGCGTTGGCCAAGGGTGACCAAGAATATGGCCCAGGTGACCAAAGCCCTGGACAAGGCCCTGAGCACCATGGACCTGCAGA AGGTCTCCTCAGTGATGGACAGGTTCGAGCAGCAGGTGCAGAACCTGGACGTCCATACATCGGTGATGGAGGACTCCATGAGCTCGGCCA CCACCCTGACCACGCCGCAGGAGCAGGTGGACAGCCTCATCATGCAGATCGCCGAGGAGAATGGCCTGGAGGTGCTGGACCAGCTCAGCC AGCTGCCCGAGGGCGCCTCTGCCGTGGGCGAGAGCTCTGTGCGCAGCCAGGAGGACCAGCTGTCACGGAGGTTGGCCGCCTTGAGGAACT AGCCGTGCCCCGCCGGTGTGCACCGCCTCTGCCCCGTGATGTGCTGGAAGGCTCCTGTCCTCTCCCCACCGCGTCTTGCCTTTGTGCTGA CCCCGCGGGGCTGCGGCCGGCAGCCACTCTGCGTCTCTCACCTGCCAGGCCTGCGTGGCCTTAGGGTTGTTCCTGTTCTTTTAGGTTGGG CGGTGGGTCTGTGTCCTGGTGTTGAGTTTCTGCAAATTTCTGGGGGTGATTTCTGTGACTCTGGGCCCACAGCGGGGAGGCCAAGAGGGG CCCTGTGGACTTTCACCCAGCACTGTGGGGGCCTTCAGACTCTGGGGCAGCAGACATGCTGCTTCCCATCAGCCAGAGGGGGTCAGGGCT GCCCTGTTGCCAAACAACTCCCTGAGGCCTCTCCGCACCACCTCAGCGGGCAGGAGGTCCCACCATGTGGACAGACATAGCCCAAGGAGG CACCACAGGTCTATGTGTGCTGGGGGATGTCAGGTGCCACCCAACGCTGTCCTGGTGGTATTTACAATGACATCCTCCTCCTCCATCACT CCAGGGGTGGTGTCTCGGCCGCCCCTACCAGCTGGCTGAGCCCCCTGGCCTCCTGCGCTCCCTCACTTCCCTCAGTTCCCAAAGCTGCCC AGTCCATGGGGACAGAACCGTCACTCAGATCCACATTCAAGTGTGCCCACCCTGCAGTCTTCATCCTCACTCAGCTGCTGCCTCTGGAGG TGCCTTTGGCCACATGTGCTGTGCTGTTTGTCTCCTCGACAGGGAGCCTGTCCACCAGCAGGCTGCGGTCCCAGCGGGTGCGTCTGCAGC TCCTCCCCTTGGGCAGCCTGGTTCTCCCGGAGGACCTTTCCTTGGGGCCCTGCTTCATGACGATGCTGCCTGTGTCACCCTCTACCATCT GTAAACAACTGGGTGCCTTCCCCGACCACACCCCAATGCCTTCCCAGCTTGGAAGCCAAGGCAGCTGATGAAGGGAGCTCAGGAGAGCCG TCTTCAGCTGGGCTGGGGTTGGGGCTGCTGTGAGGAAAACCTGCCATTGTGGCCCTGGAGAGTCACCAGCAGCTCTTGGGAAGGACTTGC TGGGAGGCTGAGAGAGGCTTTGGGCACAGCCTGCTGTCTTTTCCATTTCCTAAAGTTTACTTCATTGTCTTGAGGCTTCCAGGTTTTGTT TTTGTTTTTGCCAAAGTAGAAAAGGCAGGTGGTGGGCGGCTGGCAGGGAGTGCGGGTCCCCGCCCCTCTTCAGTCCTGCCCTCCCCTCCT CAGTCCTGCCCACCCCGTGCAGCCCATGCTGAGGCTGCAGTGGTGTCGTGGGTGTTACGTGCAGGAACGTGGAGACCCTGACGTGGGCTC ACTGCGTTTGGTTTTCTTTTCAGAACTTGGGAGCCCCCAGGGAGGGGCTAGTGTTGGTAGGTCCTAGACGTGGTTCCCTCCAGCCTCCCC AAAATCAACCCTGGTGTTGAGAGAACGTCCTTCTGTCCATCGTGGGTAACAGCCTTGGGGAGGGTGCAGAGCTCTGCAGAGCCATGGGCC >In-frame_ENST00000367055_ENST00000535997_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(amino acids)=260AA_start in transcript=1_stop in transcript=783 LWWLRQRLQQIGGISGSTSTSSMLSRAVCGTSRQLAPVLGYLGSRQKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEK YQEALAKGDQEYGPGDQSPGQGPEHHGPAEGLLSDGQVRAAGAEPGRPYIGDGGLHELGHHPDHAAGAGGQPHHADRRGEWPGGAGPAQP -------------------------------------------------------------- >In-frame_ENST00000367055_ENST00000550102_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(transcript)=809nt_BP=293nt GCTGTGGTGGCTTCGGCAGCGGCTTCAGCAGATCGGCGGCATCAGCGGTAGCACCAGCACTAGCAGCATGTTGAGCCGGGCAGTGTGCGG CACCAGCAGGCAGCTGGCTCCGGTTTTGGGGTATCTGGGCTCCAGGCAGAAGCACAGCCTCCCCGACCTGCCCTACGACTACGGCGCCCT GGAACCTCACATCAACGCGCAGATCATGCAGCTGCACCACAGCAAGCACCACGCGGCCTACGTGAACAACCTGAACGTCACCGAGGAGAA GTACCAGGAGGCGTTGGCCAAGGGTGACCAAGAATATGGCCCAGGTGACCAAAGCCCTGGACAAGGCCCTGAGCACCATGGACCTGCAGA AGGTCTCCTCAGTGATGGACAGGTTCGAGCAGCAGGTGCAGAACCTGGACGTCCATACATCGGTGATGGAGGACTCCATGAGCTCGGCCA CCACCCTGACCACGCCGCAGGAGCAGGTGGACAGCCTCATCATGCAGATCGCCGAGGAGAATGGCCTGGAGGTGCTGGACCAGCTCAGCC AGCTGCCCGAGGGCGCCTCTGCCGTGGGCGAGAGCTCTGTGCGCAGCCAGGAGGACCAGCTGTCACGGAGGTTGGCCGCCTTGAGGAACT AGCCGTGCCCCGCCGGTGTGCACCGCCTCTGCCCCGTGATGTGCTGGAAGGCTCCTGTCCTCTCCCCACCGCGTCTTGCCTTTGTGCTGA >In-frame_ENST00000367055_ENST00000550102_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(amino acids)=260AA_start in transcript=1_stop in transcript=783 LWWLRQRLQQIGGISGSTSTSSMLSRAVCGTSRQLAPVLGYLGSRQKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEK YQEALAKGDQEYGPGDQSPGQGPEHHGPAEGLLSDGQVRAAGAEPGRPYIGDGGLHELGHHPDHAAGAGGQPHHADRRGEWPGGAGPAQP -------------------------------------------------------------- >In-frame_ENST00000367054_ENST00000397901_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(transcript)=2261nt_BP=287nt GTGGCTTCGGCAGCGGCTTCAGCAGATCGGCGGCATCAGCGGTAGCACCAGCACTAGCAGCATGTTGAGCCGGGCAGTGTGCGGCACCAG CAGGCAGCTGGCTCCGGTTTTGGGGTATCTGGGCTCCAGGCAGAAGCACAGCCTCCCCGACCTGCCCTACGACTACGGCGCCCTGGAACC TCACATCAACGCGCAGATCATGCAGCTGCACCACAGCAAGCACCACGCGGCCTACGTGAACAACCTGAACGTCACCGAGGAGAAGTACCA GGAGGCGTTGGCCAAGGGTGACCAAGAATATGGCCCAGGTGACCAAAGCCCTGGACAAGGCCCTGAGCACCATGGACCTGCAGAAGGTCT CCTCAGTGATGGACAGGTTCGAGCAGCAGGTGCAGAACCTGGACGTCCATACATCGGTGATGGAGGACTCCATGAGCTCGGCCACCACCC TGACCACGCCGCAGGAGCAGGTGGACAGCCTCATCATGCAGATCGCCGAGGAGAATGGCCTGGAGGTGCTGGACCAGCTCAGCCAGCTGC CCGAGGGCGCCTCTGCCGTGGGCGAGAGCTCTGTGCGCAGCCAGGAGGACCAGCTGTCACGGAGGTTGGCCGCCTTGAGGAACTAGCCGT GCCCCGCCGGTGTGCACCGCCTCTGCCCCGTGATGTGCTGGAAGGCTCCTGTCCTCTCCCCACCGCGTCTTGCCTTTGTGCTGACCCCGC GGGGCTGCGGCCGGCAGCCACTCTGCGTCTCTCACCTGCCAGGCCTGCGTGGCCTTAGGGTTGTTCCTGTTCTTTTAGGTTGGGCGGTGG GTCTGTGTCCTGGTGTTGAGTTTCTGCAAATTTCTGGGGGTGATTTCTGTGACTCTGGGCCCACAGCGGGGAGGCCAAGAGGGGCCCTGT GGACTTTCACCCAGCACTGTGGGGGCCTTCAGACTCTGGGGCAGCAGACATGCTGCTTCCCATCAGCCAGAGGGGGTCAGGGCTGCCCTG TTGCCAAACAACTCCCTGAGGCCTCTCCGCACCACCTCAGCGGGCAGGAGGTCCCACCATGTGGACAGACATAGCCCAAGGAGGCACCAC AGGTCTATGTGTGCTGGGGGATGTCAGGTGCCACCCAACGCTGTCCTGGTGGTATTTACAATGACATCCTCCTCCTCCATCACTCCAGGG GTGGTGTCTCGGCCGCCCCTACCAGCTGGCTGAGCCCCCTGGCCTCCTGCGCTCCCTCACTTCCCTCAGTTCCCAAAGCTGCCCAGTCCA TGGGGACAGAACCGTCACTCAGATCCACATTCAAGTGTGCCCACCCTGCAGTCTTCATCCTCACTCAGCTGCTGCCTCTGGAGGTGCCTT TGGCCACATGTGCTGTGCTGTTTGTCTCCTCGACAGGGAGCCTGTCCACCAGCAGGCTGCGGTCCCAGCGGGTGCGTCTGCAGCTCCTCC CCTTGGGCAGCCTGGTTCTCCCGGAGGACCTTTCCTTGGGGCCCTGCTTCATGACGATGCTGCCTGTGTCACCCTCTACCATCTGTAAAC AACTGGGTGCCTTCCCCGACCACACCCCAATGCCTTCCCAGCTTGGAAGCCAAGGCAGCTGATGAAGGGAGCTCAGGAGAGCCGTCTTCA GCTGGGCTGGGGTTGGGGCTGCTGTGAGGAAAACCTGCCATTGTGGCCCTGGAGAGTCACCAGCAGCTCTTGGGAAGGACTTGCTGGGAG GCTGAGAGAGGCTTTGGGCACAGCCTGCTGTCTTTTCCATTTCCTAAAGTTTACTTCATTGTCTTGAGGCTTCCAGGTTTTGTTTTTGTT TTTGCCAAAGTAGAAAAGGCAGGTGGTGGGCGGCTGGCAGGGAGTGCGGGTCCCCGCCCCTCTTCAGTCCTGCCCTCCCCTCCTCAGTCC TGCCCACCCCGTGCAGCCCATGCTGAGGCTGCAGTGGTGTCGTGGGTGTTACGTGCAGGAACGTGGAGACCCTGACGTGGGCTCACTGCG TTTGGTTTTCTTTTCAGAACTTGGGAGCCCCCAGGGAGGGGCTAGTGTTGGTAGGTCCTAGACGTGGTTCCCTCCAGCCTCCCCAAAATC AACCCTGGTGTTGAGAGAACGTCCTTCTGTCCATCGTGGGTAACAGCCTTGGGGAGGGTGCAGAGCTCTGCAGAGCCATGGGCCAGGTGG GGCTGCCTCAGTCCTGTCCCCTTGGGCACTGAGGAGAGGGGCCCATTCACCTTTCTCCTAGAATGCTGTTGTAAATAAACAAATGGATCC >In-frame_ENST00000367054_ENST00000397901_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(amino acids)=238AA_start in transcript=61_stop in transcript=777 MLSRAVCGTSRQLAPVLGYLGSRQKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEKYQEALAKGDQEYGPGDQSPGQG PEHHGPAEGLLSDGQVRAAGAEPGRPYIGDGGLHELGHHPDHAAGAGGQPHHADRRGEWPGGAGPAQPAARGRLCRGRELCAQPGGPAVT -------------------------------------------------------------- >In-frame_ENST00000367054_ENST00000535997_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(transcript)=2229nt_BP=287nt GTGGCTTCGGCAGCGGCTTCAGCAGATCGGCGGCATCAGCGGTAGCACCAGCACTAGCAGCATGTTGAGCCGGGCAGTGTGCGGCACCAG CAGGCAGCTGGCTCCGGTTTTGGGGTATCTGGGCTCCAGGCAGAAGCACAGCCTCCCCGACCTGCCCTACGACTACGGCGCCCTGGAACC TCACATCAACGCGCAGATCATGCAGCTGCACCACAGCAAGCACCACGCGGCCTACGTGAACAACCTGAACGTCACCGAGGAGAAGTACCA GGAGGCGTTGGCCAAGGGTGACCAAGAATATGGCCCAGGTGACCAAAGCCCTGGACAAGGCCCTGAGCACCATGGACCTGCAGAAGGTCT CCTCAGTGATGGACAGGTTCGAGCAGCAGGTGCAGAACCTGGACGTCCATACATCGGTGATGGAGGACTCCATGAGCTCGGCCACCACCC TGACCACGCCGCAGGAGCAGGTGGACAGCCTCATCATGCAGATCGCCGAGGAGAATGGCCTGGAGGTGCTGGACCAGCTCAGCCAGCTGC CCGAGGGCGCCTCTGCCGTGGGCGAGAGCTCTGTGCGCAGCCAGGAGGACCAGCTGTCACGGAGGTTGGCCGCCTTGAGGAACTAGCCGT GCCCCGCCGGTGTGCACCGCCTCTGCCCCGTGATGTGCTGGAAGGCTCCTGTCCTCTCCCCACCGCGTCTTGCCTTTGTGCTGACCCCGC GGGGCTGCGGCCGGCAGCCACTCTGCGTCTCTCACCTGCCAGGCCTGCGTGGCCTTAGGGTTGTTCCTGTTCTTTTAGGTTGGGCGGTGG GTCTGTGTCCTGGTGTTGAGTTTCTGCAAATTTCTGGGGGTGATTTCTGTGACTCTGGGCCCACAGCGGGGAGGCCAAGAGGGGCCCTGT GGACTTTCACCCAGCACTGTGGGGGCCTTCAGACTCTGGGGCAGCAGACATGCTGCTTCCCATCAGCCAGAGGGGGTCAGGGCTGCCCTG TTGCCAAACAACTCCCTGAGGCCTCTCCGCACCACCTCAGCGGGCAGGAGGTCCCACCATGTGGACAGACATAGCCCAAGGAGGCACCAC AGGTCTATGTGTGCTGGGGGATGTCAGGTGCCACCCAACGCTGTCCTGGTGGTATTTACAATGACATCCTCCTCCTCCATCACTCCAGGG GTGGTGTCTCGGCCGCCCCTACCAGCTGGCTGAGCCCCCTGGCCTCCTGCGCTCCCTCACTTCCCTCAGTTCCCAAAGCTGCCCAGTCCA TGGGGACAGAACCGTCACTCAGATCCACATTCAAGTGTGCCCACCCTGCAGTCTTCATCCTCACTCAGCTGCTGCCTCTGGAGGTGCCTT TGGCCACATGTGCTGTGCTGTTTGTCTCCTCGACAGGGAGCCTGTCCACCAGCAGGCTGCGGTCCCAGCGGGTGCGTCTGCAGCTCCTCC CCTTGGGCAGCCTGGTTCTCCCGGAGGACCTTTCCTTGGGGCCCTGCTTCATGACGATGCTGCCTGTGTCACCCTCTACCATCTGTAAAC AACTGGGTGCCTTCCCCGACCACACCCCAATGCCTTCCCAGCTTGGAAGCCAAGGCAGCTGATGAAGGGAGCTCAGGAGAGCCGTCTTCA GCTGGGCTGGGGTTGGGGCTGCTGTGAGGAAAACCTGCCATTGTGGCCCTGGAGAGTCACCAGCAGCTCTTGGGAAGGACTTGCTGGGAG GCTGAGAGAGGCTTTGGGCACAGCCTGCTGTCTTTTCCATTTCCTAAAGTTTACTTCATTGTCTTGAGGCTTCCAGGTTTTGTTTTTGTT TTTGCCAAAGTAGAAAAGGCAGGTGGTGGGCGGCTGGCAGGGAGTGCGGGTCCCCGCCCCTCTTCAGTCCTGCCCTCCCCTCCTCAGTCC TGCCCACCCCGTGCAGCCCATGCTGAGGCTGCAGTGGTGTCGTGGGTGTTACGTGCAGGAACGTGGAGACCCTGACGTGGGCTCACTGCG TTTGGTTTTCTTTTCAGAACTTGGGAGCCCCCAGGGAGGGGCTAGTGTTGGTAGGTCCTAGACGTGGTTCCCTCCAGCCTCCCCAAAATC AACCCTGGTGTTGAGAGAACGTCCTTCTGTCCATCGTGGGTAACAGCCTTGGGGAGGGTGCAGAGCTCTGCAGAGCCATGGGCCAGGTGG >In-frame_ENST00000367054_ENST00000535997_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(amino acids)=238AA_start in transcript=61_stop in transcript=777 MLSRAVCGTSRQLAPVLGYLGSRQKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEKYQEALAKGDQEYGPGDQSPGQG PEHHGPAEGLLSDGQVRAAGAEPGRPYIGDGGLHELGHHPDHAAGAGGQPHHADRRGEWPGGAGPAQPAARGRLCRGRELCAQPGGPAVT -------------------------------------------------------------- >In-frame_ENST00000367054_ENST00000550102_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(transcript)=803nt_BP=287nt GTGGCTTCGGCAGCGGCTTCAGCAGATCGGCGGCATCAGCGGTAGCACCAGCACTAGCAGCATGTTGAGCCGGGCAGTGTGCGGCACCAG CAGGCAGCTGGCTCCGGTTTTGGGGTATCTGGGCTCCAGGCAGAAGCACAGCCTCCCCGACCTGCCCTACGACTACGGCGCCCTGGAACC TCACATCAACGCGCAGATCATGCAGCTGCACCACAGCAAGCACCACGCGGCCTACGTGAACAACCTGAACGTCACCGAGGAGAAGTACCA GGAGGCGTTGGCCAAGGGTGACCAAGAATATGGCCCAGGTGACCAAAGCCCTGGACAAGGCCCTGAGCACCATGGACCTGCAGAAGGTCT CCTCAGTGATGGACAGGTTCGAGCAGCAGGTGCAGAACCTGGACGTCCATACATCGGTGATGGAGGACTCCATGAGCTCGGCCACCACCC TGACCACGCCGCAGGAGCAGGTGGACAGCCTCATCATGCAGATCGCCGAGGAGAATGGCCTGGAGGTGCTGGACCAGCTCAGCCAGCTGC CCGAGGGCGCCTCTGCCGTGGGCGAGAGCTCTGTGCGCAGCCAGGAGGACCAGCTGTCACGGAGGTTGGCCGCCTTGAGGAACTAGCCGT GCCCCGCCGGTGTGCACCGCCTCTGCCCCGTGATGTGCTGGAAGGCTCCTGTCCTCTCCCCACCGCGTCTTGCCTTTGTGCTGACCCCGC >In-frame_ENST00000367054_ENST00000550102_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(amino acids)=238AA_start in transcript=61_stop in transcript=777 MLSRAVCGTSRQLAPVLGYLGSRQKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEKYQEALAKGDQEYGPGDQSPGQG PEHHGPAEGLLSDGQVRAAGAEPGRPYIGDGGLHELGHHPDHAAGAGGQPHHADRRGEWPGGAGPAQPAARGRLCRGRELCAQPGGPAVT -------------------------------------------------------------- >In-frame_ENST00000444946_ENST00000253475_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(transcript)=2267nt_BP=300nt ACTCGTGGCTGTGGTGGCTTCGGCAGCGGCTTCAGCAGATCGGCGGCATCAGCGGTAGCACCAGCACTAGCAGCATGTTGAGCCGGGCAG TGTGCGGCACCAGCAGGCAGCTGGCTCCGGTTTTGGGGTATCTGGGCTCCAGGCAGAAGCACAGCCTCCCCGACCTGCCCTACGACTACG GCGCCCTGGAACCTCACATCAACGCGCAGATCATGCAGCTGCACCACAGCAAGCACCACGCGGCCTACGTGAACAACCTGAACGTCACCG AGGAGAAGTACCAGGAGGCGTTGGCCAAGGGTGACCAAGAATATGGCCCAGGTGACCAAAGCCCTGGACAAGGCCCTGAGCACCATGGAC CTGCAGAAGGTCTCCTCAGTGATGGACAGGTTCGAGCAGCAGGTGCAGAACCTGGACGTCCATACATCGGTGATGGAGGACTCCATGAGC TCGGCCACCACCCTGACCACGCCGCAGGAGCAGGTGGACAGCCTCATCATGCAGATCGCCGAGGAGAATGGCCTGGAGGTGCTGGACCAG CTCAGCCAGCTGCCCGAGGGCGCCTCTGCCGTGGGCGAGAGCTCTGTGCGCAGCCAGGAGGACCAGCTGTCACGGAGGTTGGCCGCCTTG AGGAACTAGCCGTGCCCCGCCGGTGTGCACCGCCTCTGCCCCGTGATGTGCTGGAAGGCTCCTGTCCTCTCCCCACCGCGTCTTGCCTTT GTGCTGACCCCGCGGGGCTGCGGCCGGCAGCCACTCTGCGTCTCTCACCTGCCAGGCCTGCGTGGCCTTAGGGTTGTTCCTGTTCTTTTA GGTTGGGCGGTGGGTCTGTGTCCTGGTGTTGAGTTTCTGCAAATTTCTGGGGGTGATTTCTGTGACTCTGGGCCCACAGCGGGGAGGCCA AGAGGGGCCCTGTGGACTTTCACCCAGCACTGTGGGGGCCTTCAGACTCTGGGGCAGCAGACATGCTGCTTCCCATCAGCCAGAGGGGGT CAGGGCTGCCCTGTTGCCAAACAACTCCCTGAGGCCTCTCCGCACCACCTCAGCGGGCAGGAGGTCCCACCATGTGGACAGACATAGCCC AAGGAGGCACCACAGGTCTATGTGTGCTGGGGGATGTCAGGTGCCACCCAACGCTGTCCTGGTGGTATTTACAATGACATCCTCCTCCTC CATCACTCCAGGGGTGGTGTCTCGGCCGCCCCTACCAGCTGGCTGAGCCCCCTGGCCTCCTGCGCTCCCTCACTTCCCTCAGTTCCCAAA GCTGCCCAGTCCATGGGGACAGAACCGTCACTCAGATCCACATTCAAGTGTGCCCACCCTGCAGTCTTCATCCTCACTCAGCTGCTGCCT CTGGAGGTGCCTTTGGCCACATGTGCTGTGCTGTTTGTCTCCTCGACAGGGAGCCTGTCCACCAGCAGGCTGCGGTCCCAGCGGGTGCGT CTGCAGCTCCTCCCCTTGGGCAGCCTGGTTCTCCCGGAGGACCTTTCCTTGGGGCCCTGCTTCATGACGATGCTGCCTGTGTCACCCTCT ACCATCTGTAAACAACTGGGTGCCTTCCCCGACCACACCCCAATGCCTTCCCAGCTTGGAAGCCAAGGCAGCTGATGAAGGGAGCTCAGG AGAGCCGTCTTCAGCTGGGCTGGGGTTGGGGCTGCTGTGAGGAAAACCTGCCATTGTGGCCCTGGAGAGTCACCAGCAGCTCTTGGGAAG GACTTGCTGGGAGGCTGAGAGAGGCTTTGGGCACAGCCTGCTGTCTTTTCCATTTCCTAAAGTTTACTTCATTGTCTTGAGGCTTCCAGG TTTTGTTTTTGTTTTTGCCAAAGTAGAAAAGGCAGGTGGTGGGCGGCTGGCAGGGAGTGCGGGTCCCCGCCCCTCTTCAGTCCTGCCCTC CCCTCCTCAGTCCTGCCCACCCCGTGCAGCCCATGCTGAGGCTGCAGTGGTGTCGTGGGTGTTACGTGCAGGAACGTGGAGACCCTGACG TGGGCTCACTGCGTTTGGTTTTCTTTTCAGAACTTGGGAGCCCCCAGGGAGGGGCTAGTGTTGGTAGGTCCTAGACGTGGTTCCCTCCAG CCTCCCCAAAATCAACCCTGGTGTTGAGAGAACGTCCTTCTGTCCATCGTGGGTAACAGCCTTGGGGAGGGTGCAGAGCTCTGCAGAGCC ATGGGCCAGGTGGGGCTGCCTCAGTCCTGTCCCCTTGGGCACTGAGGAGAGGGGCCCATTCACCTTTCTCCTAGAATGCTGTTGTAAATA >In-frame_ENST00000444946_ENST00000253475_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(amino acids)=260AA_start in transcript=8_stop in transcript=790 MWWLRQRLQQIGGISGSTSTSSMLSRAVCGTSRQLAPVLGYLGSRQKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEK YQEALAKGDQEYGPGDQSPGQGPEHHGPAEGLLSDGQVRAAGAEPGRPYIGDGGLHELGHHPDHAAGAGGQPHHADRRGEWPGGAGPAQP -------------------------------------------------------------- >In-frame_ENST00000337404_ENST00000253475_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(transcript)=2304nt_BP=337nt GCGCTTTCTTAAGGCCCGCGGGCGGCGCAGGAGCGGCACTCGTGGCTGTGGTGGCTTCGGCAGCGGCTTCAGCAGATCGGCGGCATCAGC GGTAGCACCAGCACTAGCAGCATGTTGAGCCGGGCAGTGTGCGGCACCAGCAGGCAGCTGGCTCCGGTTTTGGGGTATCTGGGCTCCAGG CAGAAGCACAGCCTCCCCGACCTGCCCTACGACTACGGCGCCCTGGAACCTCACATCAACGCGCAGATCATGCAGCTGCACCACAGCAAG CACCACGCGGCCTACGTGAACAACCTGAACGTCACCGAGGAGAAGTACCAGGAGGCGTTGGCCAAGGGTGACCAAGAATATGGCCCAGGT GACCAAAGCCCTGGACAAGGCCCTGAGCACCATGGACCTGCAGAAGGTCTCCTCAGTGATGGACAGGTTCGAGCAGCAGGTGCAGAACCT GGACGTCCATACATCGGTGATGGAGGACTCCATGAGCTCGGCCACCACCCTGACCACGCCGCAGGAGCAGGTGGACAGCCTCATCATGCA GATCGCCGAGGAGAATGGCCTGGAGGTGCTGGACCAGCTCAGCCAGCTGCCCGAGGGCGCCTCTGCCGTGGGCGAGAGCTCTGTGCGCAG CCAGGAGGACCAGCTGTCACGGAGGTTGGCCGCCTTGAGGAACTAGCCGTGCCCCGCCGGTGTGCACCGCCTCTGCCCCGTGATGTGCTG GAAGGCTCCTGTCCTCTCCCCACCGCGTCTTGCCTTTGTGCTGACCCCGCGGGGCTGCGGCCGGCAGCCACTCTGCGTCTCTCACCTGCC AGGCCTGCGTGGCCTTAGGGTTGTTCCTGTTCTTTTAGGTTGGGCGGTGGGTCTGTGTCCTGGTGTTGAGTTTCTGCAAATTTCTGGGGG TGATTTCTGTGACTCTGGGCCCACAGCGGGGAGGCCAAGAGGGGCCCTGTGGACTTTCACCCAGCACTGTGGGGGCCTTCAGACTCTGGG GCAGCAGACATGCTGCTTCCCATCAGCCAGAGGGGGTCAGGGCTGCCCTGTTGCCAAACAACTCCCTGAGGCCTCTCCGCACCACCTCAG CGGGCAGGAGGTCCCACCATGTGGACAGACATAGCCCAAGGAGGCACCACAGGTCTATGTGTGCTGGGGGATGTCAGGTGCCACCCAACG CTGTCCTGGTGGTATTTACAATGACATCCTCCTCCTCCATCACTCCAGGGGTGGTGTCTCGGCCGCCCCTACCAGCTGGCTGAGCCCCCT GGCCTCCTGCGCTCCCTCACTTCCCTCAGTTCCCAAAGCTGCCCAGTCCATGGGGACAGAACCGTCACTCAGATCCACATTCAAGTGTGC CCACCCTGCAGTCTTCATCCTCACTCAGCTGCTGCCTCTGGAGGTGCCTTTGGCCACATGTGCTGTGCTGTTTGTCTCCTCGACAGGGAG CCTGTCCACCAGCAGGCTGCGGTCCCAGCGGGTGCGTCTGCAGCTCCTCCCCTTGGGCAGCCTGGTTCTCCCGGAGGACCTTTCCTTGGG GCCCTGCTTCATGACGATGCTGCCTGTGTCACCCTCTACCATCTGTAAACAACTGGGTGCCTTCCCCGACCACACCCCAATGCCTTCCCA GCTTGGAAGCCAAGGCAGCTGATGAAGGGAGCTCAGGAGAGCCGTCTTCAGCTGGGCTGGGGTTGGGGCTGCTGTGAGGAAAACCTGCCA TTGTGGCCCTGGAGAGTCACCAGCAGCTCTTGGGAAGGACTTGCTGGGAGGCTGAGAGAGGCTTTGGGCACAGCCTGCTGTCTTTTCCAT TTCCTAAAGTTTACTTCATTGTCTTGAGGCTTCCAGGTTTTGTTTTTGTTTTTGCCAAAGTAGAAAAGGCAGGTGGTGGGCGGCTGGCAG GGAGTGCGGGTCCCCGCCCCTCTTCAGTCCTGCCCTCCCCTCCTCAGTCCTGCCCACCCCGTGCAGCCCATGCTGAGGCTGCAGTGGTGT CGTGGGTGTTACGTGCAGGAACGTGGAGACCCTGACGTGGGCTCACTGCGTTTGGTTTTCTTTTCAGAACTTGGGAGCCCCCAGGGAGGG GCTAGTGTTGGTAGGTCCTAGACGTGGTTCCCTCCAGCCTCCCCAAAATCAACCCTGGTGTTGAGAGAACGTCCTTCTGTCCATCGTGGG TAACAGCCTTGGGGAGGGTGCAGAGCTCTGCAGAGCCATGGGCCAGGTGGGGCTGCCTCAGTCCTGTCCCCTTGGGCACTGAGGAGAGGG >In-frame_ENST00000337404_ENST00000253475_TCGA-VS-A953-01A_SOD2_chr6_160113693_-_CHMP1A_chr16_89713739_length(amino acids)=260AA_start in transcript=45_stop in transcript=827 MWWLRQRLQQIGGISGSTSTSSMLSRAVCGTSRQLAPVLGYLGSRQKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEK YQEALAKGDQEYGPGDQSPGQGPEHHGPAEGLLSDGQVRAAGAEPGRPYIGDGGLHELGHHPDHAAGAGGQPHHADRRGEWPGGAGPAQP -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for SOD2-CHMP1A |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for SOD2-CHMP1A |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for SOD2-CHMP1A |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SOD2 | C0033578 | Prostatic Neoplasms | 8 | CTD_human |
Hgene | SOD2 | C0376358 | Malignant neoplasm of prostate | 8 | CTD_human |
Hgene | SOD2 | C0235874 | Disease Exacerbation | 7 | CTD_human |
Hgene | SOD2 | C0006826 | Malignant Neoplasms | 6 | CTD_human |
Hgene | SOD2 | C0027626 | Neoplasm Invasiveness | 6 | CTD_human |
Hgene | SOD2 | C0027651 | Neoplasms | 6 | CTD_human |
Hgene | SOD2 | C0035126 | Reperfusion Injury | 6 | CTD_human |
Hgene | SOD2 | C0086692 | Benign Neoplasm | 6 | CTD_human |
Hgene | SOD2 | C0007621 | Neoplastic Cell Transformation | 5 | CTD_human |
Hgene | SOD2 | C0018801 | Heart failure | 5 | CTD_human |
Hgene | SOD2 | C0018802 | Congestive heart failure | 5 | CTD_human |
Hgene | SOD2 | C0023212 | Left-Sided Heart Failure | 5 | CTD_human |
Hgene | SOD2 | C0235527 | Heart Failure, Right-Sided | 5 | CTD_human |
Hgene | SOD2 | C1959583 | Myocardial Failure | 5 | CTD_human |
Hgene | SOD2 | C1961112 | Heart Decompensation | 5 | CTD_human |
Hgene | SOD2 | C0006142 | Malignant neoplasm of breast | 4 | CTD_human |
Hgene | SOD2 | C0007114 | Malignant neoplasm of skin | 4 | CTD_human |
Hgene | SOD2 | C0024623 | Malignant neoplasm of stomach | 4 | CTD_human |
Hgene | SOD2 | C0025500 | Mesothelioma | 4 | CTD_human |
Hgene | SOD2 | C0027627 | Neoplasm Metastasis | 4 | CTD_human |
Hgene | SOD2 | C0036341 | Schizophrenia | 4 | PSYGENET |
Hgene | SOD2 | C0037286 | Skin Neoplasms | 4 | CTD_human |
Hgene | SOD2 | C0038356 | Stomach Neoplasms | 4 | CTD_human |
Hgene | SOD2 | C0678222 | Breast Carcinoma | 4 | CTD_human |
Hgene | SOD2 | C1257931 | Mammary Neoplasms, Human | 4 | CTD_human |
Hgene | SOD2 | C1458155 | Mammary Neoplasms | 4 | CTD_human |
Hgene | SOD2 | C1708349 | Hereditary Diffuse Gastric Cancer | 4 | CTD_human |
Hgene | SOD2 | C2239176 | Liver carcinoma | 4 | CTD_human |
Hgene | SOD2 | C4704874 | Mammary Carcinoma, Human | 4 | CTD_human |
Hgene | SOD2 | C0003873 | Rheumatoid Arthritis | 3 | CTD_human |
Hgene | SOD2 | C0007786 | Brain Ischemia | 3 | CTD_human |
Hgene | SOD2 | C0020538 | Hypertensive disease | 3 | CTD_human |
Hgene | SOD2 | C0024232 | Lymphatic Metastasis | 3 | CTD_human |
Hgene | SOD2 | C0028754 | Obesity | 3 | CTD_human |
Hgene | SOD2 | C0029408 | Degenerative polyarthritis | 3 | CTD_human |
Hgene | SOD2 | C0030567 | Parkinson Disease | 3 | CTD_human |
Hgene | SOD2 | C0086743 | Osteoarthrosis Deformans | 3 | CTD_human |
Hgene | SOD2 | C0270715 | Degenerative Diseases, Central Nervous System | 3 | CTD_human |
Hgene | SOD2 | C0524851 | Neurodegenerative Disorders | 3 | CTD_human |
Hgene | SOD2 | C0751733 | Degenerative Diseases, Spinal Cord | 3 | CTD_human |
Hgene | SOD2 | C0917798 | Cerebral Ischemia | 3 | CTD_human |
Hgene | SOD2 | C0002152 | Alloxan Diabetes | 2 | CTD_human |
Hgene | SOD2 | C0002896 | Sideroblastic anemia | 2 | CTD_human |
Hgene | SOD2 | C0003129 | Anoxemia | 2 | CTD_human |
Hgene | SOD2 | C0003130 | Anoxia | 2 | CTD_human |
Hgene | SOD2 | C0004153 | Atherosclerosis | 2 | CTD_human |
Hgene | SOD2 | C0005586 | Bipolar Disorder | 2 | PSYGENET |
Hgene | SOD2 | C0005684 | Malignant neoplasm of urinary bladder | 2 | CTD_human |
Hgene | SOD2 | C0005695 | Bladder Neoplasm | 2 | CTD_human |
Hgene | SOD2 | C0007097 | Carcinoma | 2 | CTD_human |
Hgene | SOD2 | C0007131 | Non-Small Cell Lung Carcinoma | 2 | CTD_human |
Hgene | SOD2 | C0007137 | Squamous cell carcinoma | 2 | CTD_human |
Hgene | SOD2 | C0007193 | Cardiomyopathy, Dilated | 2 | CTD_human |
Hgene | SOD2 | C0009402 | Colorectal Carcinoma | 2 | CTD_human |
Hgene | SOD2 | C0009404 | Colorectal Neoplasms | 2 | CTD_human |
Hgene | SOD2 | C0011853 | Diabetes Mellitus, Experimental | 2 | CTD_human |
Hgene | SOD2 | C0014859 | Esophageal Neoplasms | 2 | CTD_human |
Hgene | SOD2 | C0022116 | Ischemia | 2 | CTD_human |
Hgene | SOD2 | C0022658 | Kidney Diseases | 2 | CTD_human |
Hgene | SOD2 | C0026640 | Mouth Neoplasms | 2 | CTD_human |
Hgene | SOD2 | C0027540 | Necrosis | 2 | CTD_human |
Hgene | SOD2 | C0032927 | Precancerous Conditions | 2 | CTD_human |
Hgene | SOD2 | C0034535 | Radiation Syndrome | 2 | CTD_human |
Hgene | SOD2 | C0038433 | Streptozotocin Diabetes | 2 | CTD_human |
Hgene | SOD2 | C0042164 | Uveitis | 2 | CTD_human |
Hgene | SOD2 | C0085207 | Gestational Diabetes | 2 | CTD_human |
Hgene | SOD2 | C0153381 | Malignant neoplasm of mouth | 2 | CTD_human |
Hgene | SOD2 | C0162674 | Chronic progressive external ophthalmoplegia | 2 | CTD_human |
Hgene | SOD2 | C0205696 | Anaplastic carcinoma | 2 | CTD_human |
Hgene | SOD2 | C0205697 | Carcinoma, Spindle-Cell | 2 | CTD_human |
Hgene | SOD2 | C0205698 | Undifferentiated carcinoma | 2 | CTD_human |
Hgene | SOD2 | C0205699 | Carcinomatosis | 2 | CTD_human |
Hgene | SOD2 | C0242184 | Hypoxia | 2 | CTD_human |
Hgene | SOD2 | C0279626 | Squamous cell carcinoma of esophagus | 2 | CTD_human |
Hgene | SOD2 | C0282313 | Condition, Preneoplastic | 2 | CTD_human |
Hgene | SOD2 | C0546837 | Malignant neoplasm of esophagus | 2 | CTD_human |
Hgene | SOD2 | C0700292 | Hypoxemia | 2 | CTD_human |
Hgene | SOD2 | C0919267 | ovarian neoplasm | 2 | CTD_human |
Hgene | SOD2 | C1140680 | Malignant neoplasm of ovary | 2 | CTD_human |
Hgene | SOD2 | C1449563 | Cardiomyopathy, Familial Idiopathic | 2 | CTD_human |
Hgene | SOD2 | C1510432 | Radiation Sickness | 2 | CTD_human |
Hgene | SOD2 | C1563937 | Atherogenesis | 2 | CTD_human |
Hgene | SOD2 | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | SOD2 | C0001787 | Osteoporosis, Age-Related | 1 | CTD_human |
Hgene | SOD2 | C0001925 | Albuminuria | 1 | CTD_human |
Hgene | SOD2 | C0001969 | Alcoholic Intoxication | 1 | PSYGENET |
Hgene | SOD2 | C0002390 | Extrinsic allergic alveolitis | 1 | CTD_human |
Hgene | SOD2 | C0002395 | Alzheimer's Disease | 1 | CTD_human |
Hgene | SOD2 | C0002736 | Amyotrophic Lateral Sclerosis | 1 | CTD_human |
Hgene | SOD2 | C0002871 | Anemia | 1 | CTD_human |
Hgene | SOD2 | C0003493 | Aortic Diseases | 1 | CTD_human |
Hgene | SOD2 | C0004045 | Asphyxia Neonatorum | 1 | CTD_human |
Hgene | SOD2 | C0004364 | Autoimmune Diseases | 1 | CTD_human |
Hgene | SOD2 | C0006118 | Brain Neoplasms | 1 | CTD_human |
Hgene | SOD2 | C0007102 | Malignant tumor of colon | 1 | CTD_human |
Hgene | SOD2 | C0007134 | Renal Cell Carcinoma | 1 | CTD_human |
Hgene | SOD2 | C0007682 | CNS disorder | 1 | CTD_human |
Hgene | SOD2 | C0007787 | Transient Ischemic Attack | 1 | CTD_human |
Hgene | SOD2 | C0009375 | Colonic Neoplasms | 1 | CTD_human |
Hgene | SOD2 | C0011265 | Presenile dementia | 1 | CTD_human |
Hgene | SOD2 | C0011570 | Mental Depression | 1 | PSYGENET |
Hgene | SOD2 | C0011574 | Involutional Depression | 1 | CTD_human |
Hgene | SOD2 | C0011581 | Depressive disorder | 1 | PSYGENET |
Hgene | SOD2 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
Hgene | SOD2 | C0011881 | Diabetic Nephropathy | 1 | CTD_human |
Hgene | SOD2 | C0014866 | Esophageal Stenosis | 1 | CTD_human |
Hgene | SOD2 | C0014868 | Esophagitis | 1 | CTD_human |
Hgene | SOD2 | C0015695 | Fatty Liver | 1 | CTD_human |
Hgene | SOD2 | C0015967 | Fever | 1 | CTD_human |
Hgene | SOD2 | C0016059 | Fibrosis | 1 | CTD_human |
Hgene | SOD2 | C0017667 | Nodular glomerulosclerosis | 1 | CTD_human |
Hgene | SOD2 | C0018200 | Granuloma, Respiratory Tract | 1 | CTD_human |
Hgene | SOD2 | C0018800 | Cardiomegaly | 1 | CTD_human |
Hgene | SOD2 | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Hgene | SOD2 | C0020542 | Pulmonary Hypertension | 1 | CTD_human |
Hgene | SOD2 | C0020550 | Hyperthyroidism | 1 | CTD_human |
Hgene | SOD2 | C0020615 | Hypoglycemia | 1 | CTD_human |
Hgene | SOD2 | C0021364 | Male infertility | 1 | CTD_human |
Hgene | SOD2 | C0021367 | Mammary Ductal Carcinoma | 1 | CTD_human |
Hgene | SOD2 | C0021655 | Insulin Resistance | 1 | CTD_human |
Hgene | SOD2 | C0022333 | Jacksonian Seizure | 1 | CTD_human |
Hgene | SOD2 | C0022665 | Kidney Neoplasm | 1 | CTD_human |
Hgene | SOD2 | C0022672 | Acute Kidney Tubular Necrosis | 1 | CTD_human |
Hgene | SOD2 | C0023891 | Liver Cirrhosis, Alcoholic | 1 | CTD_human |
Hgene | SOD2 | C0024115 | Lung diseases | 1 | CTD_human |
Hgene | SOD2 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Hgene | SOD2 | C0024796 | Marfan Syndrome | 1 | CTD_human |
Hgene | SOD2 | C0025312 | Meningomyelocele | 1 | CTD_human |
Hgene | SOD2 | C0026764 | Multiple Myeloma | 1 | CTD_human |
Hgene | SOD2 | C0027051 | Myocardial Infarction | 1 | CTD_human |
Hgene | SOD2 | C0027726 | Nephrotic Syndrome | 1 | CTD_human |
Hgene | SOD2 | C0027746 | Nerve Degeneration | 1 | CTD_human |
Hgene | SOD2 | C0029456 | Osteoporosis | 1 | CTD_human |
Hgene | SOD2 | C0029459 | Osteoporosis, Senile | 1 | CTD_human |
Hgene | SOD2 | C0030246 | Pustulosis of Palms and Soles | 1 | CTD_human |
Hgene | SOD2 | C0030297 | Pancreatic Neoplasm | 1 | CTD_human |
Hgene | SOD2 | C0030354 | Papilloma | 1 | CTD_human |
Hgene | SOD2 | C0032580 | Adenomatous Polyposis Coli | 1 | CTD_human |
Hgene | SOD2 | C0033141 | Cardiomyopathies, Primary | 1 | CTD_human |
Hgene | SOD2 | C0033860 | Psoriasis | 1 | CTD_human |
Hgene | SOD2 | C0033937 | Psychoses, Drug | 1 | CTD_human |
Hgene | SOD2 | C0033941 | Psychoses, Substance-Induced | 1 | CTD_human |
Hgene | SOD2 | C0035222 | Respiratory Distress Syndrome, Adult | 1 | CTD_human |
Hgene | SOD2 | C0036202 | Sarcoidosis | 1 | CTD_human |
Hgene | SOD2 | C0036529 | Myocardial Diseases, Secondary | 1 | CTD_human |
Hgene | SOD2 | C0036572 | Seizures | 1 | CTD_human |
Hgene | SOD2 | C0036980 | Shock, Cardiogenic | 1 | CTD_human |
Hgene | SOD2 | C0037268 | Skin Abnormalities | 1 | CTD_human |
Hgene | SOD2 | C0037274 | Dermatologic disorders | 1 | CTD_human |
Hgene | SOD2 | C0040411 | Tongue Neoplasms | 1 | CTD_human |
Hgene | SOD2 | C0041408 | Turner Syndrome | 1 | CTD_human |
Hgene | SOD2 | C0042373 | Vascular Diseases | 1 | CTD_human |
Hgene | SOD2 | C0079744 | Diffuse Large B-Cell Lymphoma | 1 | CTD_human |
Hgene | SOD2 | C0086664 | Myelocele | 1 | CTD_human |
Hgene | SOD2 | C0149958 | Complex partial seizures | 1 | CTD_human |
Hgene | SOD2 | C0151526 | Premature Birth | 1 | CTD_human |
Hgene | SOD2 | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Hgene | SOD2 | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Hgene | SOD2 | C0153349 | Malignant neoplasm of tongue | 1 | CTD_human |
Hgene | SOD2 | C0153633 | Malignant neoplasm of brain | 1 | CTD_human |
Hgene | SOD2 | C0162309 | Adrenoleukodystrophy | 1 | CTD_human |
Hgene | SOD2 | C0162671 | MELAS Syndrome | 1 | CTD_human |
Hgene | SOD2 | C0162871 | Aortic Aneurysm, Abdominal | 1 | CTD_human |
Hgene | SOD2 | C0205641 | Adenocarcinoma, Basal Cell | 1 | CTD_human |
Hgene | SOD2 | C0205642 | Adenocarcinoma, Oxyphilic | 1 | CTD_human |
Hgene | SOD2 | C0205643 | Carcinoma, Cribriform | 1 | CTD_human |
Hgene | SOD2 | C0205644 | Carcinoma, Granular Cell | 1 | CTD_human |
Hgene | SOD2 | C0205645 | Adenocarcinoma, Tubular | 1 | CTD_human |
Hgene | SOD2 | C0205874 | Papilloma, Squamous Cell | 1 | CTD_human |
Hgene | SOD2 | C0205875 | Papillomatosis | 1 | CTD_human |
Hgene | SOD2 | C0206061 | Pneumonia, Interstitial | 1 | CTD_human |
Hgene | SOD2 | C0206062 | Lung Diseases, Interstitial | 1 | CTD_human |
Hgene | SOD2 | C0206160 | Reticulocytosis | 1 | CTD_human |
Hgene | SOD2 | C0234533 | Generalized seizures | 1 | CTD_human |
Hgene | SOD2 | C0234535 | Clonic Seizures | 1 | CTD_human |
Hgene | SOD2 | C0235974 | Pancreatic carcinoma | 1 | CTD_human |
Hgene | SOD2 | C0238281 | Middle Cerebral Artery Syndrome | 1 | CTD_human |
Hgene | SOD2 | C0238461 | Anaplastic thyroid carcinoma | 1 | CTD_human |
Hgene | SOD2 | C0242526 | Gonadal Dysgenesis, 45,X | 1 | CTD_human |
Hgene | SOD2 | C0242698 | Ventricular Dysfunction, Left | 1 | CTD_human |
Hgene | SOD2 | C0242992 | Multiple Chemical Sensitivity | 1 | CTD_human |
Hgene | SOD2 | C0268255 | Farber Lipogranulomatosis | 1 | CTD_human |
Hgene | SOD2 | C0268583 | Methylmalonic acidemia | 1 | CTD_human |
Hgene | SOD2 | C0270824 | Visual seizure | 1 | CTD_human |
Hgene | SOD2 | C0270844 | Tonic Seizures | 1 | CTD_human |
Hgene | SOD2 | C0270846 | Epileptic drop attack | 1 | CTD_human |
Hgene | SOD2 | C0271708 | Fasting Hypoglycemia | 1 | CTD_human |
Hgene | SOD2 | C0271710 | Reactive hypoglycemia | 1 | CTD_human |
Hgene | SOD2 | C0274861 | Arsenic Poisoning, Inorganic | 1 | CTD_human |
Hgene | SOD2 | C0274862 | Nervous System, Organic Arsenic Poisoning | 1 | CTD_human |
Hgene | SOD2 | C0276496 | Familial Alzheimer Disease (FAD) | 1 | CTD_human |
Hgene | SOD2 | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 1 | CTD_human |
Hgene | SOD2 | C0311375 | Arsenic Poisoning | 1 | CTD_human |
Hgene | SOD2 | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Hgene | SOD2 | C0346647 | Malignant neoplasm of pancreas | 1 | CTD_human |
Hgene | SOD2 | C0376618 | Endotoxemia | 1 | CTD_human |
Hgene | SOD2 | C0393554 | Amyotrophic Lateral Sclerosis With Dementia | 1 | CTD_human |
Hgene | SOD2 | C0422850 | Seizures, Somatosensory | 1 | CTD_human |
Hgene | SOD2 | C0422852 | Seizures, Auditory | 1 | CTD_human |
Hgene | SOD2 | C0422853 | Olfactory seizure | 1 | CTD_human |
Hgene | SOD2 | C0422854 | Gustatory seizure | 1 | CTD_human |
Hgene | SOD2 | C0422855 | Vertiginous seizure | 1 | CTD_human |
Hgene | SOD2 | C0472381 | Posterior Circulation Transient Ischemic Attack | 1 | CTD_human |
Hgene | SOD2 | C0494463 | Alzheimer Disease, Late Onset | 1 | CTD_human |
Hgene | SOD2 | C0494475 | Tonic - clonic seizures | 1 | CTD_human |
Hgene | SOD2 | C0496899 | Benign neoplasm of brain, unspecified | 1 | CTD_human |
Hgene | SOD2 | C0520459 | Necrotizing Enterocolitis | 1 | CTD_human |
Hgene | SOD2 | C0543859 | Amyotrophic Lateral Sclerosis, Guam Form | 1 | CTD_human |
Hgene | SOD2 | C0546126 | Acute Confusional Senile Dementia | 1 | CTD_human |
Hgene | SOD2 | C0740376 | Middle Cerebral Artery Thrombosis | 1 | CTD_human |
Hgene | SOD2 | C0740391 | Middle Cerebral Artery Occlusion | 1 | CTD_human |
Hgene | SOD2 | C0740392 | Infarction, Middle Cerebral Artery | 1 | CTD_human |
Hgene | SOD2 | C0740457 | Malignant neoplasm of kidney | 1 | CTD_human |
Hgene | SOD2 | C0750900 | Alzheimer's Disease, Focal Onset | 1 | CTD_human |
Hgene | SOD2 | C0750901 | Alzheimer Disease, Early Onset | 1 | CTD_human |
Hgene | SOD2 | C0750974 | Brain Tumor, Primary | 1 | CTD_human |
Hgene | SOD2 | C0750977 | Recurrent Brain Neoplasm | 1 | CTD_human |
Hgene | SOD2 | C0750979 | Primary malignant neoplasm of brain | 1 | CTD_human |
Hgene | SOD2 | C0751019 | Carotid Circulation Transient Ischemic Attack | 1 | CTD_human |
Hgene | SOD2 | C0751020 | Transient Ischemic Attack, Vertebrobasilar Circulation | 1 | CTD_human |
Hgene | SOD2 | C0751021 | Crescendo Transient Ischemic Attacks | 1 | CTD_human |
Hgene | SOD2 | C0751022 | Brain Stem Ischemia, Transient | 1 | CTD_human |
Hgene | SOD2 | C0751056 | Non-epileptic convulsion | 1 | CTD_human |
Hgene | SOD2 | C0751110 | Single Seizure | 1 | CTD_human |
Hgene | SOD2 | C0751123 | Atonic Absence Seizures | 1 | CTD_human |
Hgene | SOD2 | C0751316 | Acquired Meningomyelocele | 1 | CTD_human |
Hgene | SOD2 | C0751406 | Post-Traumatic Osteoporosis | 1 | CTD_human |
Hgene | SOD2 | C0751494 | Convulsive Seizures | 1 | CTD_human |
Hgene | SOD2 | C0751495 | Seizures, Focal | 1 | CTD_human |
Hgene | SOD2 | C0751496 | Seizures, Sensory | 1 | CTD_human |
Hgene | SOD2 | C0751651 | Mitochondrial Diseases | 1 | CTD_human |
Hgene | SOD2 | C0751845 | Middle Cerebral Artery Embolus | 1 | CTD_human |
Hgene | SOD2 | C0751846 | Left Middle Cerebral Artery Infarction | 1 | CTD_human |
Hgene | SOD2 | C0751847 | Embolic Infarction, Middle Cerebral Artery | 1 | CTD_human |
Hgene | SOD2 | C0751848 | Thrombotic Infarction, Middle Cerebral Artery | 1 | CTD_human |
Hgene | SOD2 | C0751849 | Right Middle Cerebral Artery Infarction | 1 | CTD_human |
Hgene | SOD2 | C0751851 | Arsenic Encephalopathy | 1 | CTD_human |
Hgene | SOD2 | C0751852 | Arsenic Induced Polyneuropathy | 1 | CTD_human |
Hgene | SOD2 | C0752347 | Lewy Body Disease | 1 | CTD_human |
Hgene | SOD2 | C0848676 | Subfertility, Male | 1 | CTD_human |
Hgene | SOD2 | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Hgene | SOD2 | C0878544 | Cardiomyopathies | 1 | CTD_human |
Hgene | SOD2 | C0917731 | Male sterility | 1 | CTD_human |
Hgene | SOD2 | C0917805 | Transient Cerebral Ischemia | 1 | CTD_human |
Hgene | SOD2 | C0920563 | Insulin Sensitivity | 1 | CTD_human |
Hgene | SOD2 | C0948089 | Acute Coronary Syndrome | 1 | CTD_human |
Hgene | SOD2 | C0949855 | Electron Transport Chain Deficiencies, Mitochondrial | 1 | CTD_human |
Hgene | SOD2 | C0949856 | Oxidative Phosphorylation Deficiencies | 1 | CTD_human |
Hgene | SOD2 | C0949857 | Mitochondrial Respiratory Chain Deficiencies | 1 | CTD_human |
Hgene | SOD2 | C1134719 | Invasive Ductal Breast Carcinoma | 1 | CTD_human |
Hgene | SOD2 | C1168401 | Squamous cell carcinoma of the head and neck | 1 | CTD_human |
Hgene | SOD2 | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Hgene | SOD2 | C1266042 | Chromophobe Renal Cell Carcinoma | 1 | CTD_human |
Hgene | SOD2 | C1266043 | Sarcomatoid Renal Cell Carcinoma | 1 | CTD_human |
Hgene | SOD2 | C1266044 | Collecting Duct Carcinoma of the Kidney | 1 | CTD_human |
Hgene | SOD2 | C1269683 | Major Depressive Disorder | 1 | CTD_human |
Hgene | SOD2 | C1306837 | Papillary Renal Cell Carcinoma | 1 | CTD_human |
Hgene | SOD2 | C1383860 | Cardiac Hypertrophy | 1 | CTD_human |
Hgene | SOD2 | C1527168 | Bonnevie-Ullrich Syndrome | 1 | CTD_human |
Hgene | SOD2 | C1527231 | Adrenomyeloneuropathy | 1 | CTD_human |
Hgene | SOD2 | C1527335 | Transient Ischemic Attack, Anterior Circulation | 1 | CTD_human |
Hgene | SOD2 | C1527390 | Neoplasms, Intracranial | 1 | CTD_human |
Hgene | SOD2 | C1571983 | Involutional paraphrenia | 1 | CTD_human |
Hgene | SOD2 | C1571984 | Psychosis, Involutional | 1 | CTD_human |
Hgene | SOD2 | C1623038 | Cirrhosis | 1 | CTD_human |
Hgene | SOD2 | C1855119 | Methylmalonic aciduria | 1 | CTD_human |
Hgene | SOD2 | C1859317 | Cataract and cardiomyopathy | 1 | CTD_human |
Hgene | SOD2 | C2711227 | Steatohepatitis | 1 | CTD_human |
Hgene | SOD2 | C2713442 | Polyposis, Adenomatous Intestinal | 1 | CTD_human |
Hgene | SOD2 | C2713443 | Familial Intestinal Polyposis | 1 | CTD_human |
Hgene | SOD2 | C2931822 | Nasopharyngeal carcinoma | 1 | CTD_human |
Hgene | SOD2 | C3495874 | Nonepileptic Seizures | 1 | CTD_human |
Hgene | SOD2 | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Hgene | SOD2 | C3714618 | Primary Hyperthyroidism | 1 | CTD_human |
Hgene | SOD2 | C4048158 | Convulsions | 1 | CTD_human |
Hgene | SOD2 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Hgene | SOD2 | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
Hgene | SOD2 | C4316903 | Absence Seizures | 1 | CTD_human |
Hgene | SOD2 | C4317109 | Epileptic Seizures | 1 | CTD_human |
Hgene | SOD2 | C4317123 | Myoclonic Seizures | 1 | CTD_human |
Hgene | SOD2 | C4505436 | Generalized Absence Seizures | 1 | CTD_human |
Hgene | SOD2 | C4551650 | Esophageal Stricture | 1 | CTD_human |
Hgene | SOD2 | C4721453 | Peripheral Nervous System Diseases | 1 | CTD_human |
Hgene | SOD2 | C4721845 | Marfan Syndrome, Type I | 1 | CTD_human |
Tgene | CHMP1A | C0266468 | Congenital pontocerebellar hypoplasia | 1 | GENOMICS_ENGLAND |
Tgene | CHMP1A | C3554209 | Congenital pontocerebellar hypoplasia type 8 | 1 | CTD_human;GENOMICS_ENGLAND;ORPHANET |